[#DIV28SUPER] Tenure Track Assistant or Associate Professor in the Department of Psychiatry and Behavioral Sciences at Univ of New Mexico

The Department of Psychiatry and Behavioral Sciences at the University of New Mexico School of Medicine is seeking a clinical faculty researcher, suitable for appointment at the rank of Assistant or Associate Professor in the tenure-track, with a research program focused upon substance use, to join our Addictions Division. Primary faculty appointment will be in the Department of Psychiatry and Behavioral Sciences. Salary and academic rank will be commensurate with experience and academic background.

The University of New Mexico is well-situated to foster transdisciplinary research in substance use with substance use research occurring across many departments and Centers, including the Health Sciences Departments of Psychiatry and Behavioral Sciences, Neurosciences, and Internal Medicine, the College of Population Health, the Department of Psychology, the UNM Health Sciences Clinical and Translational Science Center (CTSC), The UNM Health Sciences Transdisciplinary Research, Equity and Engagement Center for Advancing Behavioral Health (TREE Center), the UNM Health Sciences Alcohol Research Center, and the UNM Center on Alcohol, Substance Use and Addictions (CASAA). These departments and Centers offer resources for the study of behavioral and pharmacologic treatments, clinical trials including pharmacological clinical trials, neuroimaging, mechanisms of change, and rural and underserved populations.

Application information here:

https://unm.csod.com/ats/careersite/JobDetails.aspx?id=9896

 

Come be my colleague at the University of New Mexico!

Katie

 

 

Katie Witkiewitz, PhD

Regents’ Professor

Department of Psychology

Center on Alcoholism, Substance Abuse, and Addictions

MSC03-2220

University of New Mexico

Albuquerque NM 87131

Office phone: 505-277-5953

Vmail: 505-925-2334

Fax: 505-277-1394

Lab website: https://abqresearch.org/

UNM profile: http://casaa.unm.edu/kwitkiewitz.html

Pronouns: She/Her/Hers

 

[#DIV28SUPER] UNIVERSITY OF VERMONT POSTDOCTORAL RESEARCH FELLOWSHIP

UNIVERSITY OF VERMONT POSTDOCTORAL RESEARCH FELLOWSHIP

 

The Vermont Center on Behavior and Health in the UVM College of Medicine announces an NIH postdoctoral research fellowship opportunity with Dr. Stacey Sigmon in our internationally recognized center of excellence for drug abuse research. The fellow will help to lead ongoing randomized clinical trials evaluating low-barrier, technology-assisted buprenorphine treatment for individuals with opioid use disorder (OUD), as well as develop new research opportunities aimed at expanding OUD treatment access in rural, underserved areas.  Dr. Sigmon, VCBH colleagues and our 29-year training program have an exceptional track record of helping fellows to establish successful careers as independent investigators.

 

Eligibility: Applicants must have completed their training in psychology or a related discipline and be U.S. citizens or permanent residents. Outstanding trainees are selected on the basis of scholastic record, productivity and commitment to a career in drug abuse research. Individuals must be highly motivated, possess initiative and a strong desire to learn and expand their interests and expertise.

 

Appointment: 2-3 yrs. 

 

Benefits: Stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards.

 

To apply: Send application form (downloaded from VCBH website), a cover letter, curriculum vitae, statement of research interests, and 3 letters of reference to: Dr. Stacey Sigmon c/o Ms. Marissa Palmer (marissa.palmer@uvm.edu).

 

About us: The VCBH was established in 2013 with the primary aim of investigating relationships between personal behaviors and risk for chronic disease and premature death, with a specific focus on understanding mechanisms underpinning risk, and developing effective interventions and policies to promote healthy behavior. The VCBH resides within the UVM Department of Psychiatry, with additional investigators, collaborators, and advisors across 15 academic departments across the UVM College of Medicine, 7 UVM colleges, and 5 other universities. The VCBH is further strengthened by interdisciplinary collaborations with key community healthcare leaders and distinguished scientific advisory panels.

 

For more information: Contact Ms. Marissa Palmer, marissa.palmer@uvm.edu or see our website.

 

Burlington, Vermont is located in the beautiful Lake Champlain region, surrounded by the Green and Adirondack Mountains. Burlington is home to a thriving arts scene, creative entrepreneurship, great shopping, three colleges and a university, and a full range of four-season outdoor pursuits (www.vermontvacation.com). Montreal and Boston are also within easy driving distances.

 

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science

Director

Clinical Research Support Office

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] Program location updates

Hello all, 

A quick note on a small number of very recent room location changes for the convention this week (updates attached). Please also double check the final APA online program on their website (https://convention.apa.org/) or the app, in case any further last minute adjustments are made (**APA reserves the right to change session times/locations**). 

Just when you thought I could not possibly have any more emails left to send you...I strike again!

Best, 

Meredith

_______________________________

Meredith S. Berry, Ph.D.

Assistant Professor

Department of Health Education and Behavior

Department of Psychology

University of Florida

Gainesville, Florida 32611

Email: mberry@ufl.edu

[#DIV28SUPER] Division 28 and Addiction Program Highlights - APA 2019 Convention

Hello all, 

Please see attached for our exciting Division 28 program highlights for the 2019 APA convention in Chicago this week. Please also see attached for broader addiction-related programming. Feel free to distribute far and wide.  

And just a reminder that additional details on the full APA program can be found at the APA website (https://convention.apa.org/), as well as information on downloading the mobile app for easy viewing and schedule planning.  

Looking forward to seeing you in Chicago!

Best,

Meredith

_______________________________

Meredith S. Berry, Ph.D.

Assistant Professor

Department of Health Education and Behavior

Department of Psychology

University of Florida

2019 Program Chair -- Division 28 Psychopharmacology and Substance Abuse​

Gainesville, Florida 32611

Email: mberry@ufl.edu

[#DIV28SUPER] Call for Papers: Experimental and Clinical Psychopharmacology

Special Issue for April 2020 on:

Advancing the Translation Between Clinical and Preclinical Models of Individual Differences in Vulnerability in Substance Use Disorders

This special issue will provide an overview of current translational research from both human and nonhuman animal researchers investigating individual difference factors in vulnerability to drug and alcohol use disorders. The goal of this special issue is to highlight translational clinical and preclinical research and to catalyze future translational approaches in the field. We encourage submission of review articles and original research reports in these areas, including individual difference factors in environmental, trait, and/or genetic domains. We encourage research that is translational in nature and would be especially interested in paired-research articles from different laboratories that are investigating the same individual difference factors across clinical and preclinical models. If submitting paired articles, authors are also invited to submit a comment on that set of articles. Nonhuman animal research that is translatable to the human conditions and human research that can be back translated to a nonhuman model are preferred. Papers addressing a variety of substances, including alcohol, marijuana, stimulants, and opiates, and their disorders, are welcome.

Researchers in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (http://pha.edmgr.com/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on Advancing the Translation Between Clinical and Preclinical Models of Individual Differences in Vulnerability to Substance Use Disorders.  All submissions will undergo our normal peer review. Manuscripts received no later than October 1, 2019 will be considered for inclusion in the special issue. We strongly encourage individuals to contact the guest editors in advance with their ideas and a draft of the title and abstract.

Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, Melissa A. Cyders, PhD, at mcyders@iu.edu or Dustin J. Stairs, PhD, at dustinstairs@creighton.edu, or the Editor, William W. Stoops, PhD at william.stoops@uky.edu.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science

Director

Clinical Research Support Office

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] Editorial Fellowship Available for Experimental and Clinical Psychopharmacology

Experimental and Clinical Psychopharmacology announces an opening for an Editorial Fellow position, beginning January 1, 2020. The position is open to qualified candidates who hold the rank of Assistant Professor (or equivalent) and will last one year. During this time, the selected Fellow will work closely with the journal's Editor, Dr. William W. Stoops, to develop editorial and publishing proficiency, enrich scientific knowledge and bolster written communication skills. It is anticipated that the Fellow will manage approximately one new manuscript per month. This process will include identifying reviewers, making an editorial decision based on review and shepherding the manuscript through to publication if accepted, all with guidance from Dr. Stoops. The successful candidate will also be expected to participate in monthly meetings with Dr. Stoops to ensure goals are met and problems are identified and addressed. The majority of these meetings will be phone conferences, although in-person meetings at scientific conferences are also possible. Upon successful completion of the fellowship, the Editorial Fellow will become a member of the journal's editorial board. All applications should include the following: 1) an interest statement, 2) a curriculum vitae and 3) three recommendation letters. Application materials are due to Dr. Stoops (william.stoops@uky.edu) on September 1, 2019 at 5 PM Eastern time and should be submitted as a single pdf file. Applications will be reviewed by members of the Experimental and Clinical Psychopharmacology editorial board for strength of the interest statement, research and publishing experience, manuscript review experience and enthusiasm of the recommendation letters. The top candidate will be notified of her/his selection by December 1, 2019. Address any questions to Dr. Stoops at william.stoops@uky.edu.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science

Director

Clinical Research Support Office

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28M] Postdoctoral Opportunity in Behavioral Pharmacology of Substance Use Disorder

The Collins Laboratory in the Department of Pharmacology at the University of Texas Health Science Center at San Antonio (UTHSCSA) is seeking a highly motivated and creative Postdoctoral Fellow to conduct innovative NIDA- and VA-funded research on the behavioral pharmacology of Substance Use Disorders. Current research in our laboratory is focused on: 1) investigating behavioral and neuropharmacological factors that underlie the development of compulsive drug taking; 2) understanding how interactions among drugs at the center of the current overdose epidemic (e.g., methamphetamine and fentanyl) impact their abuse-related and toxic effects; and 3) developing novel polypharmacy approaches to targeting dopamine and serotonin systems for the treatment of substance use disorder. Through this fellowship, the selected candidate will gain expertise in a variety of behavioral techniques, including rodent self-administration and implantable telemetry, as well as the application of quantitative analyses to the study of drugs, drug-drug interactions, and behavior. The selected candidate will be encouraged to develop an independent line of research. Additional structured opportunities for scientific and career development are provided by a NIDA-funded T32 training grant.

Eligibility: Candidates should have a recent doctoral degree in Pharmacology, Neuroscience, Experimental Psychology, or a related discipline, and a strong interest in conducting drug abuse research. Prior experience with rodent or non-human primate behavior is preferred, but not essential.

To apply: Send a CV, a brief statement of research/training goals, and the names and contact information of three references to Gregory T. Collins, Ph.D. (collinsg@uthscsa.edu). Review of applications will begin immediately and continue until the position is filled.

UTHSCSA is an Equal Opportunity/Affirmative Action Employer.

__________________ Div28m@lists.apa.org ___________________
restricted to APA members subscribers corner: http://lists.apa.org